Publicaties over Syringomyelie

Hieronder een overzicht van publicaties over Syringomyelie.

Referenties

Das A, Puvanendran K: Syringomyelia and complex regional pain syndrome as complications of multiple Sclerose. ArchNeurol 56:1021-1024, 1999.
Milhorat TH, Chou MW, Trinidad EM, et al: Chiari I malformation redefined: clinical and radiographic findings for 364 symptomatic patients. Neurosurgery 44:1005-1017, 1999.
Perl ER: Causalgia, pathological pain, and adrenergic receptors. Proc Natl Acad Sci USA 96:7664-7667, 1999.
Furst S: Transmitters involved in antinociception in the spinal cord. Brain Res Bull 48:129-141, 1999.
van Gijn J, Giesbergen PC, Hoogenraad TU: Attacks of pain in the leg from classic syringomyelia. J Neurol Neurosurg Psychiatry63:410, 1997 (Letter).

Yezierski RP: Pain following spinal cord injury: the clinical problem and experimental studies. Pain 68:185-194, 1996.
Milhorat TH, Kotzen RM, Mu HT, et al: Dysesthetic pain in patients with syringomyelia. Neurosurgery 38:940-947, 1996.
Milhorat TH, Mu HT, LaMotte CC, et al: Distribution of substance P in the spinal cord of patients with syringomyelia. JNeurosurg 84:992-998, 1996.
Hida K, Iwasaki Y, Koyanagi I, et al: Surgical indication and results of foramen magnum decompression versus syringosubarachnoid shunting for syringomyelia associated with Chiari I malformation. Neurosurgery 37:673-679, 1995.
Milhorat TH, Johnson RW, Milhorat RH, et al: Clinicopathological correlations in syringomyelia using axial magnetic resonance imaging. Neurosurgery 37:206-213, 1995.

Epstein FJ, Farmer JP, Freed D: Adult intramedullary spinal cord ependymomas: the result of surgery in 38 patients. J Neurosurg79:204-209, 1993.
LaMotte CC, Shapiro CM: Ultrastructural localization of substance P, metenkephalin, and somatostatin immunoreactivity in lamina X of the primate spinal cord. J Comp Neurol 306: 290-306, 1991.
McCormick PC, Torres R, Post KD, et al: Intramedullary ependymoma of the spinal cord. J Neurosurg 72:523-532, 1990.
Vita G, Haun CK, Hawkins EF, et al: Effects of experimental spinal cord transection on substance P receptors: a quantitative autoradiography study. Neuropeptides 17:147-153, 1990.
Gamache FW Jr, Ducker TB: Syringomyelia: a neurological and surgical spectrum. J Spinal Disord 3:293-298, 1990.

Chung K, Briner RP, Carlton SM, et al: Immunohistochemical localization of seven different peptides in the human spinal cord. J Comp Neurol 280:158-170, 1989
Beric A, Dimitrijevic MR, Lindblom U: Central dysesthesia syndrome in spinal cord injury patients. Pain 34:109-116, 1988
Gibson SJ, Polak JM, Katagiri T, et al: A comparison of the distributions of eight peptides in spinal cord from normal controls and cases of motor neurone disease with special reference to Onuf’s nucleus. Brain Res 474:255-278, 1988.
Davidoff G, Roth E, Guarracini M, et al: Function-limiting dysesthetic pain syndrome among traumatic spinal cord injury patients: a cross-sectional study. Pain 29:39-48, 1987.
Schoenen J, Lotstra F, Vierendeels G, et al: Substance P, enkephalins, somatostatin, cholecystokinin, oxytocin, and vasopressin in human spinal cord. Neurology 35:881-890, 1985.

Charnay Y, Paulin C, Chayvialle JA, et al: Distribution of substance P-like immunoreactivity in the spinal cord and dorsal root ganglia of the human foetus and infant. Neuroscience 10: 41-55, 1983
Helme RD, White DM: Immunohistochemical localization of substance P in postmortem rat and human spinal cord. J NeuropatholExp Neurol 42:99-105, 1983
de Lanerolle NC, LaMotte CC: The human spinal cord: substance P and methionine-enkephalin immunoreactivity. J Neurosci2:1369-1386, 1982
Pearson J, Brandeis L, Cuello AC: Depletion of substance P-containing axons in substantia gelatinosa of patients with diminished pain sensitivity. Nature 295:61-63, 1982
Hokfelt T, Vincent S, Dalsgaard CJ, et al: Distribution of substance P in brain and periphery and its possible role as a cotransmitter. Ciba Found Symp 84-106, 1982

Iversen LL, Hanley MR, Sandberg BE, et al: Substance P receptors in the nervous system and possible receptor subtypes. CibaFound Symp 186-205, 1982
Jessell TM: Substance P in nociceptive sensory neurons. CibaFound Symp 225-248, 1982
Nomura H, Shiosaka S, Inagaki S, et al: Distribution of substance P-like immunoreactivity in the lower brainstem of the human foetus: an immunohistochemical study. Brain Res 252: 315-325, 1982
Otsuka M, Konishi S, Yanagisawa M, et al: Role of substance P as a sensory transmitter in spinal cord and sympathetic ganglia. Ciba Found Symp 13-34, 1982
Gillberg PG, Aquilonius SM, Eckernas SA, et al: Choline Acetyltransferase and substance P-like immunoreactivity in the human spinal cord: changes in amyotrophic lateral Sclerose. Brain Res 250:394-397, 1982

Henry JL: Relation of substance P to pain transmission: neurophysiological evidence. Ciba Found Symp 206-224, 1982
Cooper PE, Fernstrom MH, Rorstad OP, et al: The regional distribution of somatostatin, substance P and neurotensin in human brain. Brain Res 218:219-232, 1981
Harmar A, Keen P: Chemical characterization of substance P-like immunoreactivity in primary afferent neurones. Brain Res220:203-207, 1981
Konishi S, Tsunoo A, Yanaihara N, et al: Peptidergic excitatory and inhibitory synapses in mammalian sympathetic ganglia: roles of substance P and enkephalin. Biomed Res 1:528-536, 1980

Williams B: Orthopaedic features in the presentation of syringomyelia. J Bone Joint Surg (Br) 61:314-323, 1979
Naftchi NE, Abrahams SJ, St. Paul HM, et al: Localization and changes of substance P in spinal cord of paraplegic cats. BrainRes 153:507-513, 1978
Henry JL: Effects of substance P on functionally identified units in cat spinal cord. Brain Res 114:439-451, 1976

Prof. dr. J.M. Keppel Hesselink, Drs. D.J. Kopsky, arts
‘Publicaties over Syringomyelie’

Bekijk hier de video’s van onze artsen.